Stephen Basso
Chief Financial OfficerMr. Stephen Basso served as Chief Financial Officer & Chief Operating Officer of Cybrexa, Inc. from November 2022 until 2023. He was Chief Financial Officer of Cybrexa, Inc. from May 2021 to November 2022. He serves as Chief Financial Officer at Innoviva, Inc. since August 21, 2023. Prior to joining Inozyme Pharma, Mr. Basso held a variety of positions at Alexion Pharmaceuticals, Inc. or Alexion, including vice president, North America commercial and global general and administrative finance from May 2016 to May 2017, vice president, corporate financial planning and analysis from February 2014 to May 2016, executive director, finance from July 2011 to February 2014 and senior director, finance and planning from January 2009 to July 2011. He has extensive experience in the financial services industry and financial leadership in the pharmaceutical industry. Prior to joining Alexion, Mr. Basso served in various finance roles at Pfizer Inc. He served as Director of Financial Planning and Analysis at Pfizer. Mr. Basso received a B.S. in Business Finance from Providence College and an M.B.A. in Finance from Boston College.
Positions
- Company NameInnoviva, Inc.Stock CodeINVAPositionChief Financial OfficerColleagues
- PRPavel RaifeldCEO & Director
- MZMarianne ZhenChief Accounting Officer & Secretary
- PMPatricia M. DrakeChief Commercial Officer-Innoviva Specialty Therapeutics, Inc.
- DADavid AltaracChief Medical Officer of IST
- JAJules A. HaimovitzIndependent Director
- SJSarah J. SchlesingerIndependent Director
- JLJosephine LindenIndependent Director
